Status:
COMPLETED
Study of Carboplatin and Vinorelbine in Malignant Pleural Mesothelioma
Lead Sponsor:
Rigshospitalet, Denmark
Conditions:
Malignant Pleural Mesothelioma
Eligibility:
All Genders
18-85 years
Phase:
PHASE2
Brief Summary
The purpose is to evaluate the activity and feasibility of a two drug regimen which is partly orally and partly intravenous in advanced pleural mesothelioma.
Detailed Description
Chemotherapy with carboplatin i.v. day one in each cycle Vinorelbine i.v. day one, and orally day 8 in each cycle, repeat new cycle every 3 weeks. Total of 6 cycles. Endpoint is response rate, second...
Eligibility Criteria
Inclusion
- Histologically verified malignant pleural Mesothelioma
- Age above 18 years
- Performance status 0-2
Exclusion
- No previous chemotherapy
- Normal renal, liver and bone marrow function
Key Trial Info
Start Date :
September 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2009
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT00272558
Start Date
September 1 2004
End Date
September 1 2009
Last Update
September 18 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dept. Oncol., Rigshospitalet
Copenhagen, Copenhagen, Denmark, 2100